ELVN · Categories · Form 3

ELVN - SEC Form 3 initial insider statements

Enliven Therapeutics Inc. (ELVN) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for ELVN

• 107d
  SEC Form 3 filed by new insider Garland J. Scott

  3 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 135d
  SEC Form 3 filed by new insider Fair Richard A.

  3 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 746d
  New insider Kunkel Lori Anne claimed ownership of 45,926 shares (SEC Form 3)

  3 - Enliven Therapeutics, Inc. (0001672619) (Issuer)

Other ELVN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends